Vyome Biosciences

Deal gives Vyome entry into the fast-growing market for next-generation autoimmune and inflammatory disease drugs

Vyome is an innovation driven clinical stage bio-pharmaceutical company, which has a pipeline of novel drugs for antibiotic resistant acne